Overview

A Study of Lu AF82422 in Participants With Multiple System Atrophy

Status:
Not yet recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lundbeck A/S